Claris Injectables Limited Chacharwadi Vasna

Form 483 issued August 26, 2016 · Ahmedabad, India

Inspection
Aug 16 – Aug 26, 2016
Observations
1
Pages
5
FEI number
3004610460

In short: On August 26, 2016, FDA issued a Form 483 with 1 observation to Claris Injectables Limited Chacharwadi Vasna in Ahmedabad, Gujarat (FEI 3004610460) after an inspection that ran Aug 16 – Aug 26, 2016. The investigators were Anastasia M. Shields and Angela E. Glenn. Most observations concern production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written production and process control procedures are not followed in the execution of production…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Claris Injectables Limited Chacharwadi Vasna?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected Claris Injectables Limited Chacharwadi Vasna?

Anastasia M. Shields and Angela E. Glenn are named on this Form 483, for the inspection of Aug 16 – Aug 26, 2016. Each investigator has a profile showing what they cite most.

When was Claris Injectables Limited Chacharwadi Vasna inspected by FDA?

The inspection ran Aug 16 – Aug 26, 2016, and the Form 483 is dated August 26, 2016.

How do I get the full Form 483 for Claris Injectables Limited Chacharwadi Vasna?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free